PTC
KRYS icon

Private Trust Company’s Krystal Biotech KRYS Stock Holding History

Private Trust Company’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32
Closed -$3.97K – 2304
2023
Q4 		$3.97K Buy
32
+9
+39% +$998 ﹤0.01% 2003
2023
Q3 		$2.67K Buy
+23
New +$2.81K ﹤0.01% 2062

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Private Trust Company's KRYS Position: Q1 2024 in Review

Private Trust Company sold out of Krystal Biotech (KRYS) in Q1 2024, closing a stake of 32 shares — an estimated $3.97K sold.

Private Trust Company first reported a position in KRYS in Q3 2023 and held it in 2 quarters. The position peaked at $3.97K in Q4 2023. 234 funds tracked by Wall St. Rank hold KRYS as of Q1 2024.

  • Private Trust Company reported no remaining Krystal Biotech position as of Q1 2024 after selling out during the quarter.
  • Private Trust Company sold 32 Krystal Biotech shares in Q1 2024, an estimated $3.97K.
  • Private Trust Company first reported a position in Krystal Biotech in Q3 2023 and held it in 2 quarters.
  • Private Trust Company's Krystal Biotech position peaked at $3.97K in Q4 2023.
  • 234 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2024.

Based on Private Trust Company's 13F filing for Q1 2024, filed 24 Apr 2024.